Boundless Bio’s $100 Million Series C Financing

Wilson Sonsini Goodrich & Rosati advised Boundless Bio on IP matters related to the transaction.Boundless Bio, a clinical-stage, next-generation precision oncology company developing innovative therapeutics directed…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now